SynLaia Innovations
Overview
Overview
Advancing human health with mechanomics.
At SynLaia we are unlocking tissue-scale disease mechanism through multi-modal spatial biology, bioengineered and in silico tissue models. Our goal is to combine cell and tissue mechanics with molecular profiling to identify novel disease mechanisms and target them.
Meet Our Team
We are a dedicated team of expert scientists, innovators and operators.
Founders
Agata Nyga
CEO
Adrien Hallou
CTO
Advisors
Nicola Wallis
Pharma consultant
ex SVP Biology @ Astex Pharmaceuticals & GSK
Nick Brown
Data & AI Leader
VP AI @ Envision Pharma,
ex Exec Head of Predictive Data & AI @ AZ
Our Team Background
Our team comes from diverse academic and professional backgrounds, with shaped expertise across different sectors
